Ki67 and progesterone receptor status predicts sensitivity to palbociclib: a real-world study

BACKGROUND: Palbociclib combined with endocrine therapy has been approved as a front-line treatment for hormone receptor positive (HR+), human epidermal growth factor receptor 2 negative (HER2−) advanced breast cancer (ABC). A key challenge remains to uncover biomarkers to identify those patients wh...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Ann Transl Med
Main Authors: Shao, Xiying, Zheng, Yabing, Cao, Wenming, Shen, Xiabo, Li, Guangliang, Chen, Junqing, Huang, Yuan, Huang, Ping, Shi, Lei, Ye, Weiwu, Zou, Weibin, Lou, Caijin, Lei, Lei, Huang, Jian, Chen, Zhanhong, Wang, Xiaojia
Formato: Artigo
Idioma:Inglês
Publicado em: AME Publishing Company 2021
Assuntos:
Original Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC8106007/
https://ncbi.nlm.nih.gov/pubmed/33987405
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/atm-21-1340
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados